Image de couverture de livre

Plasma circulating microRNAs and symptoms of depression: Results from a population‐based study

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Midas M. Kuilman, Tim Finke, M. Arfan Ikram, Annemarie I. Luik, Alexander Neumann, Charlotte A.M. Cecil, Mohsen Ghanbari
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Psychiatry and Clinical Neurosciences
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Association of objective body shape and perceived body image with depressive symptoms in men and women
par: Seong‐Uk Baek, et autres
Publié: (2025)

Dynamic cognitive differences between internal and external attention are associated with depressive and anxiety symptoms
par: Taiki Oka, et autres
Publié: (2025)

Effects of childhood experiences of parental attitude, depressive rumination, and sleep disturbances on adulthood depressive symptoms
par: Shinichi Akiyama, et autres
Publié: (2024)

Improvement in avoidance in major depressive disorder: A 10‐month prospective study of depressive symptoms and personality traits
par: Ryotaro Higuchi, et autres
Publié: (2026)

Effects of particulate matter exposures on depressive symptom trajectories: Evidence from a national longitudinal survey in China
par: Hengchang Wang, et autres
Publié: (2026)

Association between the Japanese‐style diet and low prevalence of depressive symptoms: Japan Epidemiology Collaboration on Occupational Health Study
par: Haruka Miyake, et autres
Publié: (2025)

White matter alterations in the corpus callosum and visual cortical regions associated with depressive and psychotic symptoms in early‐onset bipolar disorder
par: Zheng Bi, et autres
Publié: (2026)

Serum fetuin‐A in major depressive disorder: Lower levels in patients, but no correlation with symptom severity
par: Atsuko Ikenouchi, et autres
Publié: (2025)

Efficacy and safety of each class of sleep medication for major depressive disorder with insomnia symptoms: A systematic review and meta‐analysis of double‐blind randomized controlled trials
par: Taku Maruki, et autres
Publié: (2025)

Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline
par: Takashi Ozaki, et autres
Publié: (2025)

Smartphone cognitive behavioral therapy for prevention of depressive symptoms in patients with recurrent pregnancy loss: an exploratory decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial
par: Sakura Ogasawara, et autres
Publié: (2025)

A 2‐year longitudinal study of the association between unhealthy lifestyle factors and the development of depressive symptoms in university students
par: Ryuji Furihata, et autres
Publié: (2024)

Mediation effects of subjective social status and personality traits between childhood nurturing experiences and depressive symptoms in adult volunteers
par: Yuki Nakagawa, et autres
Publié: (2024)

The longitudinal patterns of depression subtypes and stressors in depression severity in the Canadian longitudinal study on aging (CLSA)
par: Yingying Su, et autres
Publié: (2024)

Acute prefrontal hemodynamic responses to intermittent theta burst stimulation correlate with current depression and episode recurrence: A cross‐sectional study
par: Minxia Jin, et autres
Publié: (2026)

Evaluation of depression at 6 and 12 months postpartum by examining depressive symptoms and self‐harm ideation during the early postpartum period: Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study
par: Masatsugu Orui, et autres
Publié: (2024)

Transdiagnostic approach for neuropsychiatric symptoms using neuroimage
par: Shinsuke Koike
Publié: (2025)

Early identification of postpartum depression using machine learning
par: Yukako Nakamura, et autres
Publié: (2024)

Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia
par: Christopher B. Morrow, et autres
Publié: (2025)

Autopsy case of polymicrogyria and periventricular nodular heterotopia with psychotic symptoms
par: Kazuhiro Takeda, et autres
Publié: (2026)

Habenular volume changes after venlafaxine treatment in patients with major depression
par: Josselin Etienne, et autres
Publié: (2024)

Comparison of multiple non‐invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta‐analysis of randomized controlled trials
par: Ping Wang, et autres
Publié: (2025)

Neurobiological fingerprints of negative symptoms in schizophrenia identified by connectome‐based modeling
par: Ziyang Gao, et autres
Publié: (2025)

Functional and structural connectivity of thalamic subnuclei in major depressive disorder at 7 Tesla
par: Weijian Liu, et autres
Publié: (2026)

Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
par: Yasmin Esmaeilian, et autres
Publié: (2026)

Comparison of depression with anxious distress and melancholic depression from the perspective of psychomotor disturbance
par: Yu Tamada, et autres
Publié: (2024)

Adverse childhood experiences exacerbate peripheral symptoms of autism spectrum disorder in adults
par: Kazuki Okumura, et autres
Publié: (2024)

Decoupling of amygdala–salience circuit associated with negative symptoms in adolescents with early‐onset schizophrenia
par: Manqi Zhang, et autres
Publié: (2026)

Altered cardiac timing neural avalanche in major depressive disorder: new insights from magnetoencephalography
par: Qian Liao, et autres
Publié: (2025)

From relay station to circuit hub: Thalamic subnuclear precision and the major depressive disorder dysfunctome
par: Yuehua Zhao, et autres
Publié: (2026)

Correction to “Functional near‐infrared spectroscopy as a biomarker of TMS efficacy in treatment‐resistant depression”
Publié: (2025)

Response to ‘Potential role of anti‐inflammatory cytokines in postpartum depression: Considerations for future research and improvement’
par: Chiaki T. Ono, et autres
Publié: (2024)

Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
par: Junneng Shao, et autres
Publié: (2026)

Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
par: Beatrice Bravi, et autres
Publié: (2024)

Acute and long‐term effects of repeated ketamine infusions in treatment‐resistant depression and associated metabolite changes
par: Hitoshi Sakurai, et autres
Publié: (2025)

The effects of potentially traumatic events on the recovery from pre‐existing anxiety and depression symptomatology and the risk of PTSD
par: Peter G. van der Velden, et autres
Publié: (2024)

Two‐year impact of COVID‐19: Longitudinal MRI brain changes and neuropsychiatric trajectories
par: Ravi Dadsena, et autres
Publié: (2025)

Neuropsychiatric symptoms and neuroimaging‐based brain age in mild cognitive impairment and early dementia: A multicenter study
par: Daichi Sone, et autres
Publié: (2025)

The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
par: Sara Medved, et autres
Publié: (2024)

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
par: Chieh‐Hsin Lin, et autres
Publié: (2025)